Chronic Cytopenia
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Efficacy of Abatacept for Treating Chronic Cytopenia in Cytotoxic T-Lymphocyte Antigen 4 (CTLA4) Haploinsufficiency (NCT03733067) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-11-30 |
Track Chronic Cytopenia automatically
Every clearance here is in the API, with alerts when new ones post.